People · Operator
Named in public records as an officer, director or promoter · active 2011–2019 · Other Technology, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Waste Repurposing International, Inc. | — | Other Technology | Series B | $38.9M | $238.8M | 2019 |
| Green Rush Group, Inc. | — | Other | Series B | $23.5M | $332.3M | 2018 |
| Nerveda Llc | — | Biotechnology | Series A | $18.0M | $141.0M | 2011 |
James Weil at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Weil on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cam Gallagher | 1 | 7 |
| Daniel Oros | 1 | 4 |
| Adam Cohen | 1 | 3 |
| Eddie Miller | 1 | 2 |
| Jacqueline Claudia | 1 | 2 |
| Christopher Ripley | 1 | 2 |
| James A. Weil | 1 | 1 |
| Tom Vetrano | 1 | 1 |
| Paul Warshaw | 1 | 1 |
| Chris Buggraeve | 1 | 1 |
| Michelson Lawrence | 1 | 1 |
| Lawrence Michaelson | 1 | 1 |
| David Maurer-Hollaender | 1 | 1 |
| Rob Ades | 1 | 1 |
| Debra Widmann | 1 | 1 |
| Stewart Reid | 1 | 1 |
| Thomas Lionelli | 1 | 1 |
| Odo Habeck | 1 | 1 |
| David Lerner | 1 | 1 |
| Chris Ripley | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.